F-Pharma Inc.

Overview

F-Pharma Inc. is a biopharmaceutical company focused on discovering and developing innovative therapies for various medical conditions. The company aims to address unmet medical needs in the healthcare industry.

Therapeutic areas

API / Drug Master Files

F-Pharma Inc. holds 3 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CALCIUM CARBONATE, MAG. HYDROXIDE GRANActive2024-06-14
• MAGNESIUM HYDROXIDE USP BARCROFT™ 5100 CG POWDERActive2024-03-06
• CALCIUM CARBONATE DC TYPE CS90 PRODUCTSActive2008-02-27
• ACTIMASK® IBUPROFEN 92SInactive2017-04-13
• BARCROFT™ 5100 CG MAGNESIUM HYDROXIDE POWDER USPInactive2015-06-23
• BULK ACTIMASK TASTE MASKED ACETAMINOPHENInactive2011-08-05
• MAGNESIUM HYDROXIDE DC MS90 PRODUCTSInactive2009-02-06
• BARCROFT(TM) 5300D MAGNESIUM HYDROXIDE USPInactive2006-04-07
• MAGNESIUM HYDROXIDE PASTE/POWDER USPInactive2001-03-19
• DRIED ALUMINUM HYDROXIDE GEL, USPInactive1998-10-01
• CALCIUM CARBONATE/STARCH GRANULATIONInactive1992-04-24
• MANNOGEM® MANNITOL USP PRODUCTSInactive1964-05-13

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to F-Pharma Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.